PeptideDB

N-Benzyl-L-isoleucine 1859-49-0

N-Benzyl-L-isoleucine 1859-49-0

CAS No.: 1859-49-0

N-Benzyl-L-isoleucine is an isoleucine analogue.
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

N-Benzyl-L-isoleucine is an isoleucine analogue.

Physicochemical Properties


Molecular Formula C13H19NO2
Molecular Weight 221.30
Exact Mass 221.142
CAS # 1859-49-0
PubChem CID 6994933
Appearance White to off-white solid powder
LogP 2.666
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 3
Rotatable Bond Count 6
Heavy Atom Count 16
Complexity 212
Defined Atom Stereocenter Count 2
SMILES

CC[C@H](C)[C@@H](C(=O)O)NCC1=CC=CC=C1

InChi Key GPAVORZIWQTJJQ-JQWIXIFHSA-N
InChi Code

InChI=1S/C13H19NO2/c1-3-10(2)12(13(15)16)14-9-11-7-5-4-6-8-11/h4-8,10,12,14H,3,9H2,1-2H3,(H,15,16)/t10-,12-/m0/s1
Chemical Name

(2S,3S)-2-(benzylamino)-3-methylpentanoic acid
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro Commercial ergot supplements have been made from amino acids and their derivatives. They affect the release of anabolic hormones, the availability of fuel for activity, the ability to think clearly under pressure, and the prevention of muscular damage brought on by exertion. They are regarded as advantageous synergistic food ingredients [1].
References

[1]. Effects of amino acid derivatives on physical, mental, and physiological activities. Crit Rev Food Sci Nutr. 2015;55(13):1793-1144.


Solubility Data


Solubility (In Vitro) DMSO: 9.09 mg/mL (41.08 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 0.91 mg/mL (4.11 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 9.1 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 2: ≥ 0.91 mg/mL (4.11 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 9.1 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 4.5188 mL 22.5938 mL 45.1875 mL
5 mM 0.9038 mL 4.5188 mL 9.0375 mL
10 mM 0.4519 mL 2.2594 mL 4.5188 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.